Thurnheer R, Bingisser R, Stammberger U, Muntwyler J, Zollinger A, Bloch K E, Weder W, Russi E W
Department of Internal Medicine, University Hospital of Zurich, Switzerland.
Eur J Cardiothorac Surg. 1998 Mar;13(3):253-8. doi: 10.1016/s1010-7940(98)00008-6.
The presence of pulmonary hypertension in severe pulmonary emphysema has been considered a relative contraindication to lung volume reduction surgery (LVRS). There was concern that resection of lung tissue might further increase pulmonary artery pressure. To address this point, the prevalence of pulmonary hypertension in candidates for LVRS was investigated. The changes in pulmonary artery pressures after bilateral videoassisted thoracoscopic resection was studied in patients with homo- and heterogeneously destroyed emphysematous lungs.
The pulmonary arterial pressures by right heart catheterization were prospectively assessed, before and 6 months after LVRS in 21 consecutive patients (15 males, six females, mean (+/- S.E.) age: 62 +/- 1.9, range 42-74 years). All were former smokers and three had ZZ-AT1 deficiency. The inclusion criteria were: (a) severe bronchial obstruction (FEV1 < 35% predicted); (b) pulmonary hyperinflation (RV/TLC > 0.60); and (c) absence of hypercapnia (PaCO2 < 50 mmHg).
The FEV1 had increased from 28 +/- 2% to 35 +/- 3% of the predicted value (P < 0.05) 6 months after surgery. The RV/TLC had declined from 0.65 +/- 0.02 to 0.55 +/- 0.02; PaO2 increased (66 +/- 1 versus 71 +/- 2 mmHg, P = 0.04), PaCO2 (38 +/- 2 versus 36 +/- 1 mmHg, P = 0.26) did not change. The pulmonary artery mean pressure (PAPmean) remained unchanged (18 +/- 1 versus 19 +/- 1 mmHg, P = 0.26). In six patients PAPmean was > or = 20 mmHg (up to 24 mmHg) preoperatively. After 6 months, six patients had a PAPmean > or = 20 mmHg (up to 31 mmHg).
In patients with severe emphysema who are candidates for LVRS (but have only mild to moderate hypoxemia and a PaCO2 < 50 mmHg) we found no relevant pulmonary hypertension and pulmonary artery pressure did not change significantly after surgery. Therefore, routine right heart catheterization is not mandatory for preoperative evaluation.
重度肺气肿患者合并肺动脉高压一直被视为肺减容手术(LVRS)的相对禁忌证。人们担心切除肺组织可能会进一步升高肺动脉压力。为阐明这一点,对肺减容手术候选者中肺动脉高压的患病率进行了调查。研究了双侧电视辅助胸腔镜切除术后,均匀性和非均匀性破坏的肺气肿患者肺动脉压力的变化。
对21例连续患者(15例男性,6例女性,平均(±标准误)年龄:62±1.9岁,范围42 - 74岁)在肺减容手术前及术后6个月通过右心导管插入术前瞻性评估肺动脉压力。所有患者均为既往吸烟者,3例有ZZ - AT1缺乏症。纳入标准为:(a)严重支气管阻塞(FEV1<预测值的35%);(b)肺过度充气(RV/TLC>0.60);(c)无高碳酸血症(PaCO2<50 mmHg)。
术后6个月,FEV1从预测值的28±2%增至35±3%(P<0.05)。RV/TLC从0.65±0.02降至0.55±0.02;PaO2升高(66±1对71±2 mmHg,P = 0.04),PaCO2(38±2对36±1 mmHg,P = 0.26)未改变。肺动脉平均压(PAPmean)保持不变(18±1对19±1 mmHg,P = 0.26)。术前6例患者PAPmean≥20 mmHg(最高达24 mmHg)。6个月后,6例患者PAPmean≥20 mmHg(最高达31 mmHg)。
在适合肺减容手术(但仅有轻度至中度低氧血症且PaCO2<50 mmHg)的重度肺气肿患者中,我们未发现明显的肺动脉高压,且术后肺动脉压力无显著变化。因此,术前评估无需常规进行右心导管插入术。